Charles D. Goodwin II is CEO at Apyx Medical Corp (APYX). They have made 3 open-market trades across 1 company since 2020, most recently 2023-11-14.
CIK 0001726988
3 open-market purchases totalling $300K since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| APYX | 90,000 | $230K |
Shares reported on the most recent Form 4, priced at the 2023-11-15 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.